New derivatives of pyrrolo[3,4-d]pyridazinone and their anticancer effects
- 30 June 2004
- journal article
- Published by Elsevier BV in Il Farmaco
- Vol. 59 (6), 457-462
- https://doi.org/10.1016/j.farmac.2004.03.002
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Aloisines, a New Family of CDK/GSK-3 Inhibitors. SAR Study, Crystal Structure in Complex with CDK2, Enzyme Selectivity, and Cellular EffectsJournal of Medicinal Chemistry, 2002
- Pharmacological inhibitors of cyclin-dependent kinasesTrends in Pharmacological Sciences, 2002
- Synthesis of 5-Substituted Pyrrolo[1,2-b]pyridazines with Antioxidant PropertiesArchiv der Pharmazie, 2001
- Synthesis and Antiproliferative and Antiviral Activity of Carbohydrate-Modified Pyrrolo[2,3-d]pyridazin-7-one NucleosidesJournal of Medicinal Chemistry, 1997
- Biochemical and Cellular Effects of Roscovitine, a Potent and Selective Inhibitor of the Cyclin‐Dependent Kinases cdc2, cdk2 and cdk5JBIC Journal of Biological Inorganic Chemistry, 1997
- Sequential Dephosphorylation of p34 on Thr-14 and Tyr-15 at the Prophase/Metaphase TransitionOnline Journal of Public Health Informatics, 1996
- Synthesis, antiproliferative, and antiviral activity of 4-amino-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d]pyridazin-7(6H)-one and related derivativesJournal of Medicinal Chemistry, 1993
- Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell LinesJNCI Journal of the National Cancer Institute, 1991